Dr. Björn Steiniger-Brach
Angestellt, Medical Director, UCB Biosciences
Brussel (Anderlecht), Belgien
Werdegang
Berufserfahrung von Björn Steiniger-Brach
Bis heute 7 Jahre und 9 Monate, seit Sep. 2016
Medical Director
UCB Biosciences
Bis heute
Senior Medical Advisor
H. Lundbeck A/S
9 Monate, Jan. 2016 - Sep. 2016
Medical and Scientific Consultant
BSBR Scientific
3 Jahre und 8 Monate, Feb. 2013 - Sep. 2016
Senior Medical Advisor
H. Lundbeck A/S
o Global lead late stage study program o Investigator initiated trials o Responsibility for the scientific communication strategy o Support of regulatory, marketing and market access activities o Global partner for affiliate medical organisations
11 Monate, Apr. 2012 - Feb. 2013
Medical Advisor
H. Lundbeck A/S
o Late stage study program o Investigator initiated trials o Global Scientific communication strategy o Disease and product training through: lectures, written documents and e-learning tools o Organization and execution of scientific congresses, global advisory boards and expert meetings o Establishment and maintenance of external collaborations with scientific experts
3 Jahre und 4 Monate, Dez. 2008 - März 2012
Principal Scientist
H. Lundbeck A/S
Biology lead for psychiatric and neurological discovery and development projects. o Laboratory head: management of a group of technicians and scientists, supervision of PhD and master students. o Project management within drug discovery o Support of business development initiatives and due diligence projects o Scientific communication, to internal or external professional audience o External collaborations and participation in public private partnership projects
3 Jahre und 4 Monate, Aug. 2005 - Nov. 2008
Research Scientist
H. Lundbeck A/S
o Biology support for psychiatric and neurological discovery and development projects. o Laboratory head: management of a group of technicians and master students. o Scientific communication, to internal or external professional audience
2 Jahre und 3 Monate, Mai 2003 - Juli 2005
Scientist
Johnson & Johnson, (Janssen Pharmaceutica NV)
Developed methodology and technology to study effects of drugs on affective spektrum disorders. In vivo scientists supporting discoverz and development stage projects
Ausbildung von Björn Steiniger-Brach
2000 - 2004
Neurowissenschaften
Universität Tübingen
Neuropharmakologie. Neurochemie, psychiatrische und neurologische Erkrankungen
2000 - 2000
Pharmacology, Neuroscience
Karolinska Institutet
Forschungsaufenthalt am Dept. of Physiology & Pharmacology, Karolinska Institutet, Sweden
1995 - 1997
Biologie
Universität Bremen
Grundstudium
Sprachen
Deutsch
Muttersprache
Englisch
Fließend
Dänisch
Gut